Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 21 citing Stride: β-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte.... (0.07 sec) 

Minireview: Pharmacogenetics and Beyond: The Interaction of Therapeutic Response,{beta}- …


AT Hattersley, ER Pearson - Endocrinology, 2006 - Endocrine Soc
Defining the molecular genetics of diabetes gives new insight into the
underlying etiology and so should help improve treatment. The genetic etiology
is now known for most patients with ß-cell monogenic diabetes, allowing ...
Cited by 42 - Related articles - BL Direct - All 8 versions

Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha …


S Ellard, K Colclough - Human mutation, 2006 - interscience.wiley.com
Maturity-onset diabetes of the young (MODY) is a monogenic form of diabetes
mellitus characterized by autosomal dominant inheritance, early age of onset
(often <25 years of age), and pancreatic -cell dysfunction. MODY is both ...
Cited by 32 - Related articles - BL Direct - All 4 versions

Clinical implications of a molecular genetic classification of monogenic β-cell diabetes


R Murphy, S Ellard, AT Hattersley - Nature Clinical Practice Endocrinology & Metabolism, 2008 - nature.com
Sian Ellard is Professor of Human Molecular Genetics, Peninsula Medical School,
Exeter, UK. Following research training at the University of Swansea (UK), she
set up the Molecular Genetics Laboratory in Exeter with Professor Andrew ...
Cited by 31 - Related articles - BL Direct - All 6 versions

Common variants in HNF-1 α and risk of type 2 diabetes


J Holmkvist, C Cervin, V Lyssenko, W Winckler … - Diabetologia, 2006 - Springer
Page 1. ARTICLE Common variants in HNF-1 α and risk of type 2 diabetes J.
Holmkvist & C. Cervin & V. Lyssenko & W. Winckler & D. Anevski ...
Cited by 27 - Related articles - BL Direct - All 4 versions

Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of …

- nih.gov
S Ellard, C Bellanne-Chantelot, AT Hattersley - Diabetologia, 2008 - Springer
Abstract Aims/hypothesis Mutations in the GCK and HNF1A genes are the most
common cause of the monogenic forms of diabetes known as 'maturity-onset
diabetes of the young'. GCK encodes the glucokinase enzyme, which acts as ...
Cited by 16 - Related articles - BL Direct - All 11 versions

Adolescents at risk for MODY3 diabetes prefer genetic testing before adulthood

- Free from Publisher
B Liljeström, T Tuomi, B Isomaa, L Sarelin, K … - Diabetes care, 2007 - Am Diabetes Assoc
Mutations in the hepatocyte nuclear factor (HNF)-1α gene cause an autosomally,
dominantly inherited form of diabetes, maturity-onset diabetes of the young
(MODY) type 3, which is characterized by poor insulin secretion in response ...
Cited by 1 - Related articles - BL Direct - All 6 versions

Clinical application of 1, 5-anhydroglucitol measurements in patients with HNF-1α MODY.


PHD MD - Am Diabetes Assoc
1 Department of Metabolic Diseases, Jagiellonian University, Medical College,
Krakow, Poland 2 Department of Internal Medicine, Diabetology and Nephrology,
Silesian School of Medicine, Zabrze, Poland 3 BioMarker Group, Kannapolis, ...
Related articles

[PDF] Genetic testing clarifies diagnosis and treatment in a family with both HNF1A and type 1 …


M Shepherd, PD RGN - Practical Diabetes International, 2009 - practicaldiabetesinternational.com
Introduction Making a diagnosis of diabetes may be straightforward when blood
glu- cose levels reach the levels indicated by the World Health Organization
(WHO), with a fasting blood glucose ≥7.0mmol/L (126mg/dl) or two- hour ...
Related articles - View as HTML - All 3 versions

[PDF] Current Insights into the Genetic Basis of Diabetes Mellitus in Children and Adolescents


Ó Rubio-Cabezas, J Argente - Journal of Pediatric Endocrinology & Metabolism, 2008 - ciberobn.es
Diabetes mellitus (DM) is one of the most common chronic diseases in children
and adolescents, and type 1 DM accounts for more than 95% of cases.
Nevertheless, over the last years it has become apparent that not all cases ...
Related articles - View as HTML - All 3 versions

Clinical Application of 1, 5-Anhydroglucitol Measurements in Patients with Hepatocyte …

- nih.gov - Free from Publisher
J Skupien, S Gorczynska-Kosiorz, T Klupa, K … - Diabetes Care, 2008 - Am Diabetes Assoc
OBJECTIVE—1,5-anhydroglucitol (1,5-AG) is a short-term marker of metabolic
control in diabetes. Its renal loss is stimulated in hyperglycemic conditions by
glycosuria, which results in a lowered plasma concentration. As a low renal ...
Related articles - All 6 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google